Neurocrine Biosciences Inc vs Nano Dimension Ltd - ADR — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Nano Dimension Ltd - ADR trades at $1.49 (market cap $322.08M). The key difference: Neurocrine Biosciences Inc is far larger — about 54× Nano Dimension Ltd - ADR's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Nano Dimension Ltd - ADR nearer its low. Which is the better fit depends on your goals.
| NBIX | NNDM | |
|---|---|---|
Market Cap | $17.40B | $322.08M |
Sector | Health | Technology |
52-Week High | $180.55 | $2.14 |
52-Week Low | $123.10 | $1.21 |
Enterprise Value | $16.49B | -$87.26M |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →